KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
77 hedge funds and large institutions have $328M invested in Chinook Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+7
Holders Change %
+10%
% of All Funds
1.37%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
25
Increased
30
Reduced
16
Closed
17
Calls
$493K
Puts
$1.09M
Net Calls
-$600K
Net Calls Change
-$604K
Top Buyers
1 |
ALSV
ATP Life Science Ventures
New York
|
+$63.9M |
2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$19.8M |
3 |
O
OrbiMed
New York
|
+$19.8M |
4 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$11.9M |
5 |
BBA
Baker Bros. Advisors
New York
|
+$11.9M |